KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Invested Capital (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 14 years of Return on Invested Capital data on record, last reported at 0.2% in Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 17.0% year-over-year to 0.2%; the TTM value through Dec 2025 reached 0.2%, up 17.0%, while the annual FY2025 figure was 0.2%, 17.0% up from the prior year.
  • Return on Invested Capital reached 0.2% in Q4 2025 per VRTX's latest filing, up from 0.19% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.29% in Q2 2022 and bottomed at 0.15% in Q1 2025.
  • Average Return on Invested Capital over 5 years is 0.18%, with a median of 0.2% recorded in 2021.
  • The widest YoY moves for Return on Invested Capital: up 17bps in 2025, down -34bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.24% in 2021, then grew by 3bps to 0.25% in 2022, then decreased by -27bps to 0.18% in 2023, then plummeted by -83bps to 0.03% in 2024, then surged by 535bps to 0.2% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 0.2% in Q4 2025, 0.19% in Q3 2025, and 0.19% in Q2 2025.